Shingles on the forearm
Find information on thousands of medical conditions and prescription drugs.

Herpes zoster

Herpes zoster, colloquially known as shingles, is the reactivation of varicella zoster virus, leading to a crop of painful blisters over the area of a dermatome. It occurs very rarely in children and adults, but its incidence is high in the elderly (over 60), as well as in any age group of immunocompromised patients. It affects some 500,000 people per year in the United States. Treatment is generally with antiviral drugs such as acyclovir. Many patients develop a painful condition called postherpetic neuralgia which is often difficult to manage. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

In some patients, herpes zoster can reactivate subclinically with pain in a dermatomal distribution without rash. This condition is known as zoster sine herpete and may be more complicated, affecting multiple levels of the nervous system and causing multiple cranial neuropathies, polyneuritis, myelitis, or aseptic meningitis.

The word herpes came from Greek, which is cognate with serpent and, as can be expected, herpetology. Interestingly, the skin disease is also commonly known as "snake" in Chinese.

Signs and symptoms

Often, pain is the first symptom. This pain can be characterized as stinging, tingling, numbing, or throbbing, and can be pronounced with quick stabs of intensity. Then 2-3 crops of red lesions develop, which gradually turn into small blisters filled with serous fluid. A general feeling of unwellness often occurs.

As long as the blisters have not dried out, HZ patients may transmit the virus to others. This could lead to chickenpox in people (mainly young children) who are not yet immune to this virus.

Shingles blisters are unusual in that they only appear on one side of the body. That is because the chickenpox virus can remain dormant for decades, and does so inside the spinal column or a nerve fiber. If it reactivates as shingles, it affects only a single nerve fiber, or ganglion, which can radiate to only one side of the body. The blisters therefore only affect one area of the body and do not cross the midline. They are most common on the torso, but can also appear on the face (where they are potentially hazardous to vision) or other parts of the body.

Diagnosis

The diagnosis is visual — very few other diseases mimic herpes zoster. In case of doubt, fluid from a blister may be analysed in a medical laboratory.

Pathophysiology

The causative agent for herpes zoster is varicella zoster virus (VZV). Most people are infected with this virus as a child, as it causes chickenpox. The body eliminates the virus from the system, but it remains dormant in the ganglia adjacent to the spinal cord or the ganglion semilunare (ganglion Gasseri) in the cranial base.

Generally, the immune system suppresses reactivation of the virus. In the elderly, whose immune response generally tends to deteriorate, as well as in those patients whose immune system is being suppressed, this process fails. (Some researchers speculate that sunburn and other, unrelated stresses that can affect the immune system may also lead to viral reactivation.) The virus starts replicating in the nerve cells, and newly formed viruses are carried down the axons to the area of skin served by that ganglion (a dermatome). Here, the virus causes local inflammation in the skin, with the formation of blisters.

Read more at Wikipedia.org


[List your site here Free!]


Herpes zoster vaccine safe and effective for older adults
From Journal of Family Practice, 9/1/05 by M.N. Oxman

Oxman MN, Levin MJ, Johnson GR, et al, for the Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-2284.

* Clinical Question

Can a vaccine prevent herpes zoster and postherpetic neuralgia?

* Bottom Line

Herpes zoster vaccine is safe and effective for the prevention of herpes zoster and postherpetic neuralgia in older adults. The number needed to treat is quite large on an annual basis, particularly for postherpetic neuralgia. Even if the number needed to treat (NNT) of 1111 is linear for a 10-year period, one would have to vaccinate 111 older patients to prevent 1 case of postherpetic neuralgia during that period. The number needed to treat to prevent a case of herpes zoster is 175. Given the strength of this vaccination and the target population, long-term follow-up studies are needed to identify any unexpected but serious complications that may appear down the road. (LOE=1b)

Study Design

Randomized controlled trial (double-blinded)

Allocation

Concealed

Setting

Outpatient (any)

Synopsis

Patients with herpes zoster (shingles) feel miserable, and postherpetic neuralgia-which complicates about 10% of cases-makes them feel even worse. This study identified adults older than 60 years (47% were older than 70 years) who had either a history of varicella or were presumed to have one because they had lived in the United States for at least 30 years. A total of 59% were men, 95% were white, and they had a generally good baseline health status.

Patients were randomized (allocation concealed) to receive either 0.5 mL of live attenuated Oka/Merck varicella-zoster virus vaccine (n=19,270) or placebo (n=19,276). The vaccine is 14 times stronger than the vaccine used to prevent primary varicella infection in children. Groups were balanced at baseline and analysis was by intention to treat. Patients were followed for a median of 3.1 years, and 95% of patients completed the study, which is excellent. The primary outcomes were the number of episodes of herpes zoster and postherpetic neuralgia; cases within 30 days of vaccination and second episodes were excluded.

Fewer patients in the vaccination group developed herpes zoster (11.1 vs 5.4 episodes per 1000 person-years; P<.001; NNT=175 per year). Patients in the vaccinated group also had a somewhat shorter course (21 vs 24 days; P=.03) and were less likely to develop postherpetic neuralgia (0.48 vs 1.38 per 1000 person-years; P<.001; NNT=1111). The benefit was more pronounced in patients aged 60 years to 69 years than in older patients.

Safety is an important issue in prevention studies since we are treating otherwise healthy patients. Safety was monitored in 2 ways: by patient or physician report for the entire population, and by diary entries for a subset of 6716 patients. For the entire study population, there was no difference in mortality between groups and no difference in possible vaccine-related adverse events, either during the first 42 days or for the duration of the 3-year study. For the adverse event substudy group, one or more adverse events-primarily erythema, pain, swelling or pruritus at the injection site-occurred more often during the first 42 days. As noted above, this is a higher-potency vaccine; the current vaccine used for children should not be used for adults.

COPYRIGHT 2005 Dowden Health Media, Inc.
COPYRIGHT 2005 Gale Group

Return to Herpes zoster
Home Contact Resources Exchange Links ebay